Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

India flag India · Delayed Price · Currency is INR
139.45
+6.64 (5.00%)
Apr 17, 2026, 2:37 PM IST
Market Cap3.30B +76.6%
Revenue (ttm)1.47B -0.5%
Net Income96.61M +124.8%
EPS4.09 +125.1%
Shares Out23.66M
PE Ratio34.12
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,521
Average Volume6,110
Open138.00
Previous Close132.81
Day's Range126.30 - 139.45
52-Week Range71.57 - 202.06
Beta-0.02
RSI65.44
Earnings DateMay 26, 2026

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP. [Read more]

Sector Healthcare
Founded 1981
Employees 406
Stock Exchange National Stock Exchange of India
Ticker Symbol BAFNAPH
Full Company Profile

Financial Performance

In fiscal year 2025, Bafna Pharmaceuticals's revenue was 1.46 billion, a decrease of -4.33% compared to the previous year's 1.52 billion. Earnings were 41.53 million, a decrease of -43.49%.

Financial Statements